Koulich E, Nguyen T, Johnson K, Giardina C, D'mello S
Department of Molecular and Cell Biology, University of Texas at Dallas, Richardson, USA.
J Neurochem. 2001 Feb;76(4):1188-98. doi: 10.1046/j.1471-4159.2001.00134.x.
The NF-kappaB transcription factor consists of dimeric complexes belonging to the Rel family, which include p50, p52, p65 (RelA), RelB and c-Rel. NF-kappaB activity is tightly controlled by IkappaB proteins which bind to NF-kappaB preventing its translocation to the nucleus. Activation of NF-kappaB is most often mediated by IkappaB degradation, which permits NF-kappaB to enter the nucleus. We investigated the role of NF-kappaB in the survival of cerebellar granule neurons. We found that survival of these neurons in high potassium medium is blocked by three separate inhibitors of NF-kappaB activity: SN-50, N-tosyl-L-phenylalanine chloromethyl ketone and pyrrolidinedithiocarbamate, indicating that NF-kappaB is required for neuronal survival. Gel-shift assays reveal three complexes that bind to the NF-kappaB binding site in high potassium medium. Switching these cultures to low potassium medium, a stimulus that leads to apoptotic death, causes a reduction in the level of the largest complex, which contains p65. Overexpression of p65 by transfection inhibits low potassium-induced apoptosis, whereas overexpression of IkappaBalpha promotes apoptosis even in high potassium medium. Surprisingly, however, neither the level of endogenous p65 nor that of IkappaBalpha and IkappaBbeta is altered by low potassium treatment. Similarly, no changes are seen in the nuclear or cytoplasmic levels of p50, p52, RelB and c-Rel. Phosphorylation of p65, which can lead to its activation, is unchanged. Phosphorylation of IkappaBbeta is, however, reduced by low potassium treatment. Besides being necessary for high potassium-mediated neuronal survival, NF-kappaB is also involved in the survival-promoting effects of IGF-1 and cAMP as judged by the ability of SN-50 to inhibit the actions of these survival factors and the ability of these factors to inhibit the low potassium-induced alterations in the DNA-binding activity of NF-kappaB. Taken together, our results show that NF-kappaB may represent a point of convergence in the signaling pathways activated by different survival factors and that uncommon mechanisms might be involved in NF-kappaB-mediated survival of cerebellar granule neurons.
核因子-κB转录因子由属于Rel家族的二聚体复合物组成,其中包括p50、p52、p65(RelA)、RelB和c-Rel。核因子-κB的活性受到IκB蛋白的严格控制,IκB蛋白与核因子-κB结合,阻止其转运至细胞核。核因子-κB的激活通常由IκB降解介导,这使得核因子-κB能够进入细胞核。我们研究了核因子-κB在小脑颗粒神经元存活中的作用。我们发现,在高钾培养基中这些神经元的存活被三种不同的核因子-κB活性抑制剂阻断:SN-50、N-对甲苯磺酰-L-苯丙氨酸氯甲基酮和吡咯烷二硫代氨基甲酸盐,这表明核因子-κB是神经元存活所必需 的。凝胶迁移试验揭示了在高钾培养基中与核因子-κB结合位点结合的三种复合物。将这些培养物转换至低钾培养基,这一刺激会导致凋亡性死亡,会使最大的复合物(包含p65)水平降低。通过转染过表达p65可抑制低钾诱导的凋亡,而过表达IκBα即使在高钾培养基中也会促进凋亡。然而,令人惊讶的是,低钾处理既未改变内源性p65的水平,也未改变IκBα和IκBβ的水平。同样,p50、p52、RelB和c-Rel的核内或胞质水平也未见变化。可导致p65激活的p65磷酸化未改变。然而,低钾处理会降低IκBβ的磷酸化。除了对高钾介导的神经元存活是必需的之外,根据SN-50抑制这些存活因子作用的能力以及这些因子抑制低钾诱导的核因子-κB DNA结合活性改变的能力判断,核因子-κB还参与胰岛素样生长因子-1和环磷酸腺苷的促存活作用。综上所述,我们的结果表明,核因子-κB可能代表了由不同存活因子激活的信号通路中的一个汇聚点,并且不常见的机制可能参与了核因子-κB介导的小脑颗粒神经元存活过程。